CA
RMD icon

Clearstead Advisors’s ResMed RMD Stock Holding History

Clearstead Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.4K Sell
171
-1,642
-91% -$409K ﹤0.01% 1329
2025
Q4 		$437K Buy
1,813
+1,071
+144% +$274K 0.01% 698
2025
Q3 		$203K Buy
742
+96
+15% +$26.2K ﹤0.01% 878
2025
Q2 		$167K Buy
646
+626
+3,130% +$149K ﹤0.01% 927
2025
Q1 		$4.48K Sell
20
-236
-92% -$55.1K ﹤0.01% 1772
2024
Q4 		$58.6K Sell
256
-31
-11% -$7.46K ﹤0.01% 1129
2024
Q3 		$70K Sell
287
-286
-50% -$63.9K ﹤0.01% 1124
2024
Q2 		$110K Buy
573
+1
+0.2% +$203 ﹤0.01% 978
2024
Q1 		$125K Sell
572
-34
-6% -$6.23K 0.01% 559
2023
Q4 		$104K Sell
606
-580
-49% -$89.1K 0.01% 578
2023
Q3 		$175K Buy
1,186
+626
+112% +$113K 0.01% 597
2023
Q2 		$122K Buy
560
+359
+179% +$80K 0.01% 527
2023
Q1 		$44K Buy
201
+18
+10% +$3.9K ﹤0.01% 690
2022
Q4 		$38.1K Hold
183
– – ﹤0.01% 667
2022
Q3 		$40K Hold
183
– – ﹤0.01% 652
2022
Q2 		$38K Hold
183
– – ﹤0.01% 675
2022
Q1 		$44K Hold
183
– – ﹤0.01% 711
2021
Q4 		$48K Sell
183
-8
-4% -$2.08K ﹤0.01% 664
2021
Q3 		$50K Hold
191
– – ﹤0.01% 614
2021
Q2 		$47K Buy
191
+8
+4% +$1.68K ﹤0.01% 568
2021
Q1 		$36K Hold
183
– – ﹤0.01% 586
2020
Q4 		$39K Hold
183
– – ﹤0.01% 546
2020
Q3 		$31K Hold
183
– – ﹤0.01% 536
2020
Q2 		$35K Hold
183
– – ﹤0.01% 472
2020
Q1 		$27K Buy
+183
New +$29.1K ﹤0.01% 477

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Clearstead Advisors's RMD Position: Q1 2026 in Review

Clearstead Advisors reduced its ResMed (RMD) stake by 91% in Q1 2026, selling an estimated $409K and leaving 171 shares worth $38.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1329.

Clearstead Advisors first reported a position in RMD in Q1 2020 and has held it in 25 quarters since. The position peaked at $437K in Q4 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Clearstead Advisors held 171 shares of ResMed worth $38.4K as of Q1 2026.
  • Clearstead Advisors sold 1,642 ResMed shares in Q1 2026, an estimated $409K.
  • ResMed made up ﹤0.01% of Clearstead Advisors's portfolio in Q1 2026, its #1329 holding.
  • Clearstead Advisors first reported a position in ResMed in Q1 2020 and has held it in 25 quarters since.
  • Clearstead Advisors's ResMed position peaked at $437K in Q4 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Clearstead Advisors's 13F filing for Q1 2026, filed 6 May 2026.